ICD-10-CM Billable Code

D26.7

Other benign neoplasm of other parts of uterus

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 Code D26.7 refers to a benign (non-cancerous) growth that occurs in parts of the uterus not specifically categorized elsewhere. These growths are typically non-threatening but may cause symptoms or impact reproductive health. Understanding these benign neoplasms is important for managing health and making informed medical decisions.

Causes & Symptoms

Clinical Causes: Hormonal factors, especially estrogen and progesterone imbalances Genetic predisposition or family history of uterine growths Previous uterine trauma or surgical procedures Age-related changes in hormonal levels, commonly affecting women in their reproductive years or perimenopause Certain environmental factors and lifestyle choices, though these are less clearly established

Key Symptoms: Pelvic pain or discomfort, particularly during menstruation or sexual activity Abnormal uterine bleeding, such as heavy or irregular menstrual periods A feeling of fullness or pressure in the pelvic region Enlargement or a noticeable mass in the pelvic area Many benign tumors are asymptomatic and are found incidentally during imaging studies

Diagnostic & Treatment

Diagnosis Path: Diagnosis of benign uterine neoplasms involves a combination of medical history review, pelvic examination, and imaging tests. Common diagnostic procedures include: - Ultrasound: Often the first imaging choice to visualize the uterus and identify masses - MRI (Magnetic Resonance Imaging): Provides detailed images of the uterine tissue for better characterization of the tumor - Hysteroscopy: A minimally invasive procedure to examine the inside of the uterus using a thin, lighted instrument - Biopsy: Obtaining tissue samples for histopathological examination when necessary to exclude malignancy Further tests may be ordered if there are atypical features or concerns about cancerous changes.

Treatment Protocols: Management of benign uterine neoplasms depends on factors such as the size, location, symptoms, and the patient's reproductive desires. Treatment options include: - Observation: Small, asymptomatic tumors may simply be monitored over time - Medication: Hormonal therapies like gonadotropin-releasing hormone (GnRH) agonists may help shrink tumors or control bleeding - Surgical procedures: - Myomectomy: Removal of the tumor while preserving the uterus, suitable for women desiring future pregnancies - Hysterectomy: Complete removal of the uterus, often considered in larger or symptomatic cases - Minimally invasive techniques: Uterine artery embolization or laser ablation for targeted treatment Treatment plans should be individualized, ideally discussed with healthcare providers specializing in gynecology.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D26.7 a billable ICD-10 code?
Yes, D26.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D26.7?
Clinical documentation must specify the nature of Other benign neoplasm of other parts of uterus and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

uterus neoplasm parts